Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-23-008072

President and CEO sold 42,000 shares at an average $20.99 ($881,720)

  • President and CEO acquired 42,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanjiv President and CEO 2023-02-07 Option exercise +14,000 $5.04 $70,560 14,000 D: show line 1 in the form
Patel Sanjiv President and CEO 2023-02-07 Sale −14,000 $21.45 $300,300 0 D: show line 2 in the form
Patel Sanjiv President and CEO 2023-02-08 Option exercise +14,000 $5.04 $70,560 14,000 D: show line 3 in the form
Patel Sanjiv President and CEO 2023-02-08 Sale −14,000 $20.98 $293,720 0 D: show line 4 in the form
Patel Sanjiv President and CEO 2023-02-09 Option exercise +14,000 $5.04 $70,560 14,000 D: show line 5 in the form
Patel Sanjiv President and CEO 2023-02-09 Sale −14,000 $20.55 $287,700 0 D: show line 6 in the form
Open-market sales · 42,000 sh · avg $20.99 · $881,720

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Patel Sanjiv President and CEO 2023-02-07 Option exercise · Stock Option (Right to Buy) −14,000 596,779 D: show line 7 in the form
Patel Sanjiv President and CEO 2023-02-08 Option exercise · Stock Option (Right to Buy) −14,000 582,779 D: show line 8 in the form
Patel Sanjiv President and CEO 2023-02-09 Option exercise · Stock Option (Right to Buy) −14,000 568,779 D: show line 9 in the form
Loading xslF345X03/doc4.xml…